Ambrx Biopharma Inc. Debt to Equity Ratio 2023-2023 | AMAM

Current and historical debt to equity ratio values for Ambrx Biopharma Inc. (AMAM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Ambrx Biopharma Inc. debt/equity for the three months ending June 30, 2023 was .
Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-06-30 $0.03B $0.25B 0.12
2023-03-31 $0.03B $0.18B 0.15
2022-12-31 $0.03B $0.12B 0.25
2022-06-30 $0.04B $0.14B 0.28
2022-03-31 $0.00B 0.00